These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32647222)

  • 21. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accuracy of 18F-FDG PET/CT, Multidetector CT, and MR Imaging in the Diagnosis of Pancreatic Cysts: A Prospective Single-Center Study.
    Kauhanen S; Rinta-Kiikka I; Kemppainen J; Grönroos J; Kajander S; Seppänen M; Alanen K; Gullichsen R; Nuutila P; Ovaska J
    J Nucl Med; 2015 Aug; 56(8):1163-8. PubMed ID: 26045314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic hemangioendothelioma: CT, MR, and FDG-PET-CT in 67 patients-a bi-institutional comprehensive cancer center review.
    Ganeshan D; Pickhardt PJ; Morani AC; Javadi S; Lubner MG; Elmohr MM; Duran C; Elsayes KM
    Eur Radiol; 2020 May; 30(5):2435-2442. PubMed ID: 32002639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. (18)F-FDG-PET/CT findings in pancreatic metastasis.
    Hu S; Zhang J; Zuo C; Cheng C; Liu Q; Sun G
    Radiol Med; 2015 Oct; 120(10):887-98. PubMed ID: 25795439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography in detection and presurgical assessment of pancreatic cancer: a prospective study.
    Buchs NC; Bühler L; Bucher P; Willi JP; Frossard JL; Roth AD; Addeo P; Rosset A; Terraz S; Becker CD; Ratib O; Morel P
    J Gastroenterol Hepatol; 2011 Apr; 26(4):657-62. PubMed ID: 21155879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer immunotherapy is accompanied by distinct metabolic patterns in primary and secondary lymphoid organs observed by non-invasive
    Schwenck J; Schörg B; Fiz F; Sonanini D; Forschner A; Eigentler T; Weide B; Martella M; Gonzalez-Menendez I; Campi C; Sambuceti G; Seith F; Quintanilla-Martinez L; Garbe C; Pfannenberg C; Röcken M; la Fougere C; Pichler BJ; Kneilling M
    Theranostics; 2020; 10(2):925-937. PubMed ID: 31903160
    [No Abstract]   [Full Text] [Related]  

  • 27. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.
    Santhosh S; Mittal BR; Bhasin D; Srinivasan R; Rana S; Das A; Nada R; Bhattacharya A; Gupta R; Kapoor R
    J Gastroenterol Hepatol; 2013 Feb; 28(2):255-61. PubMed ID: 23278193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Robustness of Radiomic Features in [
    Lu L; Lv W; Jiang J; Ma J; Feng Q; Rahmim A; Chen W
    Mol Imaging Biol; 2016 Dec; 18(6):935-945. PubMed ID: 27324369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical impact of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in patients with resectable pancreatic cancer: diagnosing lymph node metastasis and predicting survival.
    Kim HR; Seo M; Nah YW; Park HW; Park SH
    Nucl Med Commun; 2018 Jul; 39(7):691-698. PubMed ID: 29893751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative effectiveness of 18F-FDG PET/CT versus whole-body MRI for detection of malignant peripheral nerve sheath tumors in neurofibromatosis type 1.
    Derlin T; Tornquist K; Münster S; Apostolova I; Hagel C; Friedrich RE; Wedegärtner U; Mautner VF
    Clin Nucl Med; 2013 Jan; 38(1):e19-25. PubMed ID: 23242059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of (18) F-FDG PET/CT and CECT in conjunction with serum CA 19-9 for detecting recurrent pancreatic adenocarcinoma.
    Rayamajhi S; Balachandran A; Katz M; Reddy A; Rohren E; Bhosale P
    Abdom Radiol (NY); 2018 Feb; 43(2):505-513. PubMed ID: 28900703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variability of target and normal structure delineation using multimodality imaging for radiation therapy of pancreatic cancer.
    Dalah E; Moraru I; Paulson E; Erickson B; Li XA
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):633-40. PubMed ID: 24755533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 18F-Fluorodeoxyglucose PET/CT and dynamic contrast-enhanced MRI as imaging biomarkers in malignant pleural mesothelioma.
    Hall DO; Hooper CE; Searle J; Darby M; White P; Harvey JE; Braybrooke JP; Maskell NA; Masani V; Lyburn ID
    Nucl Med Commun; 2018 Feb; 39(2):161-170. PubMed ID: 29300270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical applications of (18)F-FDG PET in the management of hepatobiliary and pancreatic tumors.
    De Gaetano AM; Rufini V; Castaldi P; Gatto AM; Filograna L; Giordano A; Bonomo L
    Abdom Imaging; 2012 Dec; 37(6):983-1003. PubMed ID: 22527152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography in the evaluation of glioma.
    Shaw TB; Jeffree RL; Thomas P; Goodman S; Debowski M; Lwin Z; Chua B
    J Med Imaging Radiat Oncol; 2019 Oct; 63(5):650-656. PubMed ID: 31368665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of CT attenuation and FDG uptake of adipose tissue in patients with pancreatic adenocarcinoma.
    Lee JW; Lee SM; Chung YA
    Clin Radiol; 2018 Dec; 73(12):1056.e1-1056.e10. PubMed ID: 30077337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can complementary 68Ga-DOTATATE and 18F-FDG PET/CT establish the missing link between histopathology and therapeutic approach in gastroenteropancreatic neuroendocrine tumors?
    Has Simsek D; Kuyumcu S; Turkmen C; Sanlı Y; Aykan F; Unal S; Adalet I
    J Nucl Med; 2014 Nov; 55(11):1811-7. PubMed ID: 25315243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. F-18-fluorodeoxyglucose positron emission tomography in differentiating malignant from benign pancreatic cysts: a prospective study.
    Sperti C; Pasquali C; Decet G; Chierichetti F; Liessi G; Pedrazzoli S
    J Gastrointest Surg; 2005 Jan; 9(1):22-8; discussion 28-9. PubMed ID: 15623441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contrast-enhanced multiphasic CT and MRI findings of adenosquamous carcinoma of the pancreas.
    Ding Y; Zhou J; Sun H; He D; Zeng M; Rao S
    Clin Imaging; 2013; 37(6):1054-60. PubMed ID: 24035524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation.
    Anderson GS; Brinkmann F; Soulen MC; Alavi A; Zhuang H
    Clin Nucl Med; 2003 Mar; 28(3):192-7. PubMed ID: 12592125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.